JP2017501990A5 - - Google Patents

Download PDF

Info

Publication number
JP2017501990A5
JP2017501990A5 JP2016536146A JP2016536146A JP2017501990A5 JP 2017501990 A5 JP2017501990 A5 JP 2017501990A5 JP 2016536146 A JP2016536146 A JP 2016536146A JP 2016536146 A JP2016536146 A JP 2016536146A JP 2017501990 A5 JP2017501990 A5 JP 2017501990A5
Authority
JP
Japan
Prior art keywords
peptide
building block
chain
lipopeptide building
long
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016536146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017501990A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/076313 external-priority patent/WO2015082501A1/en
Publication of JP2017501990A publication Critical patent/JP2017501990A/ja
Publication of JP2017501990A5 publication Critical patent/JP2017501990A5/ja
Pending legal-status Critical Current

Links

JP2016536146A 2013-12-03 2014-12-02 肺炎連鎖球菌(S.pneumoniae)に対して防御的なプロリンリッチペプチド Pending JP2017501990A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13195402.6 2013-12-03
EP13195402 2013-12-03
PCT/EP2014/076313 WO2015082501A1 (en) 2013-12-03 2014-12-02 Proline-rich peptides protective against s. pneumoniae

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019217485A Division JP2020073487A (ja) 2013-12-03 2019-11-29 肺炎連鎖球菌(S.pneumoniae)に対して防御的なプロリンリッチペプチド

Publications (2)

Publication Number Publication Date
JP2017501990A JP2017501990A (ja) 2017-01-19
JP2017501990A5 true JP2017501990A5 (cg-RX-API-DMAC7.html) 2019-03-28

Family

ID=49765797

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016536146A Pending JP2017501990A (ja) 2013-12-03 2014-12-02 肺炎連鎖球菌(S.pneumoniae)に対して防御的なプロリンリッチペプチド
JP2019217485A Pending JP2020073487A (ja) 2013-12-03 2019-11-29 肺炎連鎖球菌(S.pneumoniae)に対して防御的なプロリンリッチペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019217485A Pending JP2020073487A (ja) 2013-12-03 2019-11-29 肺炎連鎖球菌(S.pneumoniae)に対して防御的なプロリンリッチペプチド

Country Status (12)

Country Link
US (2) US9943583B2 (cg-RX-API-DMAC7.html)
EP (1) EP3077410B1 (cg-RX-API-DMAC7.html)
JP (2) JP2017501990A (cg-RX-API-DMAC7.html)
KR (1) KR20160088323A (cg-RX-API-DMAC7.html)
CN (1) CN105793276A (cg-RX-API-DMAC7.html)
AU (1) AU2014359292B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016012306A2 (cg-RX-API-DMAC7.html)
CA (1) CA2931570A1 (cg-RX-API-DMAC7.html)
HK (1) HK1225739A1 (cg-RX-API-DMAC7.html)
RU (1) RU2737638C2 (cg-RX-API-DMAC7.html)
WO (1) WO2015082501A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201603962B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3016815A1 (en) * 2016-03-08 2017-09-14 KeMyth Biotech Co., Ltd. Use of pneumolysin peptides as antagonists against toll-like receptor 4 and methods of treating toll-like receptor 4 related diseases
US11806392B2 (en) * 2016-12-03 2023-11-07 The Uab Research Foundation Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A
RU2019142012A (ru) 2017-06-14 2021-07-14 Вирометикс Аг Циклические пептиды для защиты от респираторно-синцитиального вируса
CN108559784B (zh) * 2018-07-06 2021-08-20 陕西省动物研究所 一种同时检测三种病原菌的三重pcr检测用引物、探针、试剂盒及检测方法
CN113260377B (zh) * 2018-12-20 2025-08-22 维罗米蒂克斯股份公司 脂肽构建块和合成病毒样颗粒
WO2020192701A1 (en) * 2019-03-25 2020-10-01 Immunwork Inc. Composite polypeptide having a metal binding motif and molecular construct comprising the same
WO2021260176A1 (en) 2020-06-25 2021-12-30 Virometix Ag Synthetic epitopes of betacoronaviruses
US20230355737A1 (en) 2020-09-28 2023-11-09 Dbv Technologies Particle comprising an rsv-f protein for use in rsv vaccination
WO2025012364A1 (en) 2023-07-12 2025-01-16 Virometix Ag Compositions of pneumococcal antigens
WO2025242657A1 (en) 2024-05-21 2025-11-27 Shape Biopharmaceuticals Ag Lipopeptide building blocks and aggregates

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
GB8704647D0 (en) 1987-02-27 1987-04-01 Guy S & St Thomas S Hospitals Vaccine
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5391712A (en) 1991-08-30 1995-02-21 Beckman Instruments, Inc. Non-hemolytic streptolysin O variants
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
US6251405B1 (en) * 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
WO1997037026A1 (en) 1996-04-02 1997-10-09 Smithkline Beecham Corporation Novel compounds
EP0914330A4 (en) 1996-05-14 2002-01-09 Smithkline Beecham Corp NEW TYPE COMPOUNDS
US6096863A (en) 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
DE69739981D1 (de) 1996-10-31 2010-10-14 Human Genome Sciences Inc Streptococcus pneumoniae-Antigene und Impfstoffe
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
CA2312900A1 (en) 1997-12-02 1999-06-10 Powderject Vaccines, Inc. Transdermal delivery of particulate vaccine compositions
IT1320157B1 (it) 2000-01-27 2003-11-18 Combistone Italia S P A Piano e/o rivestimento per arredamento e procedimento per la suaproduzione.
EP1328543B1 (en) 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
EP1421098A4 (en) 2001-04-13 2006-03-15 Wyeth Corp SURFACE PROTEINS OF STREPTOCOCCUS PYOGENES
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
ES2504166T3 (es) 2002-09-13 2014-10-08 Novartis Vaccines And Diagnostics, Inc. Vacuna de estreptococo del grupo B
RU2352356C2 (ru) 2003-06-26 2009-04-20 Новартис Вэксинес Энд Дайэгностикс, Инк. ИММУНОГЕННАЯ КОМПОЗИЦИЯ НА ОСНОВЕ АНТИГЕНА Chlamydia trachomatis (ВАРИАНТЫ) И ЕЕ ИСПОЛЬЗОВАНИЕ
CA2641220A1 (en) 2006-02-02 2007-08-09 Susan K. Hollingshead Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
SI2121732T1 (sl) * 2006-12-09 2012-12-31 Universitat Zurich Prorektorat Forschung Vijačni svežnji lipopeptidov z ovito vijačnico in sintetični virusu podobni delci
MY163871A (en) * 2011-01-20 2017-10-31 Genocea Biosciences Inc Vaccines and compositions against streptococcus pneumoniae

Similar Documents

Publication Publication Date Title
JP2017501990A5 (cg-RX-API-DMAC7.html)
JP2010512308A5 (ja) コイルドコイル構造を有するリポペプチドビルディングブロック、リポペプチドヘリックスバンドル、合成ウイルス様粒子、および医薬製剤
CY1121258T1 (el) Καινοτομος ανοσοθεραπεια εναντι διαφορων ογκων συμπεριλαμβανομενων των ογκων των νευρωνων και του εγκεφαλου
RU2015146614A (ru) Конъюгированная вакцина на основе пептида антигена wt1
JP2016196472A5 (cg-RX-API-DMAC7.html)
JP2014509838A5 (cg-RX-API-DMAC7.html)
CY1123450T1 (el) Μεθοδος καθαρισμου συζευγματων βασει il-15/il-15ra
BR112016012306A2 (pt) peptídeos ricos em prolina para proteção contra s. pneumoniae
JP2010518082A5 (cg-RX-API-DMAC7.html)
JP2019537424A5 (cg-RX-API-DMAC7.html)
JP2015501656A5 (cg-RX-API-DMAC7.html)
JP2014507146A5 (cg-RX-API-DMAC7.html)
JP2014224126A5 (cg-RX-API-DMAC7.html)
JP2012501959A5 (cg-RX-API-DMAC7.html)
MX363443B (es) Proteinas de tipo espiral enrollada modificadas que tienen propiedades mejoradas.
JP2016501266A5 (cg-RX-API-DMAC7.html)
RU2017135038A (ru) Пептид, полученный из gpc3, фармацевтическая композиция для лечения или предотвращения рака с его использованием, индуктор иммунитета и способ получения антиген-презентирующих клеток
JP2008530975A5 (cg-RX-API-DMAC7.html)
JP2016516734A5 (cg-RX-API-DMAC7.html)
JP2016138090A5 (cg-RX-API-DMAC7.html)
JP2016520534A5 (cg-RX-API-DMAC7.html)
JP2015513314A5 (cg-RX-API-DMAC7.html)
JP2018536645A5 (cg-RX-API-DMAC7.html)
EP3868778A3 (en) Cdc45l peptides and vaccines including the same
JP2013501030A5 (cg-RX-API-DMAC7.html)